EuroBiotech: More Articles of Note


> ImmunoQure and Memo Therapeutics entered into a collaboration to create libraries from APS-1 memory B cells. The partners think the research will advance work on autoantibodies. Statement 

> BioMed X cleared a milestone in the Alzheimer’s disease project it initiated with AbbVie, triggering a milestone payment from the major U.S. biopharma company. Release 

> SeraNovo teamed up with Carna Biosciences to develop an oral kinase inhibitor. The partnership will make use of SeraNovo’s formulation platform. Statement 

Virtual Roundtable

ASCO Explained: Expert predictions and takeaways from the world's biggest cancer meeting

Join FiercePharma for our ASCO pre- and post-show webinar series. We'll bring together a panel of experts to preview what to watch for at ASCO. Cancer experts will highlight closely watched data sets to be unveiled at the virtual meeting--and discuss how they could change prescribing patterns. Following the meeting, we’ll do a post-show wrap up to break down the biggest data that came out over the weekend, as well as the implications they could have for prescribers, patients and drugmakers.

> The FDA cleared ObsEva to start enrolling women undergoing embryo transfer following in vitro fertilization in a phase 3 trial. The trial will test oral oxytocin receptor antagonist nolasiban. Release 

> Futura Medical shared additional data on its topical treatment for erectile dysfunction. Statement 

Suggested Articles

Last month, rumors out of Bloomberg whispered that Gilead, more known for its COVID-19 work these days, was gearing up for a major stake in Arcus.

The NGOs think Big Pharma controls the agenda of the IMI, leading it to prioritize areas that are profitable for drugmakers over public health needs.

Canadian biotech AbCellera has nabbed a meaty $105 million series B funding round as it looks to boost its antibody work and seek out new potential me